1. Signaling Pathways
  2. Anti-infection
  3. Parasite
  4. Toxoplasma Isoform
  5. Toxoplasma Inhibitor

Toxoplasma Inhibitor

Toxoplasma Inhibitors (17):

Cat. No. Product Name Effect Purity
  • HY-10373
    Trimetrexate
    Inhibitor 99.22%
    Trimetrexate (CI-898) is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR.
  • HY-116090
    Conoidin A
    Inhibitor 98.03%
    Conoidin A is a cell permeable inhibitor of T.
  • HY-101525
    MBP146-78
    Inhibitor 98.47%
    MBP146-78 is a potent and selective inhibitor of cGMP dependent protein kinases.
  • HY-B0273
    Sulfadiazine
    Inhibitor 99.86%
    Sulfadiazine is a sulfonamide antibiotic with antimalarial activity.
  • HY-100593
    Spiramycin
    Inhibitor 99.19%
    Spiramycin (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect.
  • HY-12724A
    Guanabenz hydrochloride
    Inhibitor
    Guanabenz hydrochloride is an orally active α-2-adrenoceptor agonist.
  • HY-10373B
    Trimetrexate isethionate
    Inhibitor
    Trimetrexate (CI-898) isethionate is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR.
  • HY-12724
    Guanabenz
    Inhibitor
    Guanabenz is an orally active α-2-adrenoceptor agonist.
  • HY-117015
    Purfalcamine
    Inhibitor 99.71%
    Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM.
  • HY-N9320
    13,21-Dihydroeurycomanone
    Inhibitor 98.11%
    13,21-Dihydroeurycomanone, a natural compound isolated from Eurycoma longifolia root, possesses anti-parasite activity for Plasmodium falciparum and Toxoplasma gondii.
  • HY-115972
    Anti-Trypanosoma cruzi agent-2
    Inhibitor
    Anti-Trypanosoma cruzi agent-1 (Compd 3b), selective compound against NINOA trypomastigote (IC50 = 0.51 µM) and INC-5 epimastigote form (IC50 = 3.06 µM), posseses anti-T.
  • HY-10373A
    Trimetrexate trihydrochloride
    Inhibitor
    Trimetrexate (CI-898) trihydrochloride is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR.
  • HY-147003
    MMV687807
    Inhibitor
    MMV687807 is an anthelmintic agent which has a good activity against Toxoplasma gondii (T.
  • HY-B0273S1
    Sulfadiazine-13C6
    Inhibitor
    Sulfadiazine-13C6 is a labeled Sulfadiazine (HY-B0273).
  • HY-115971
    Anti-Trypanosoma cruzi agent-1
    Inhibitor
    Anti-Trypanosoma cruzi agent-1 (Compd E5) posseses anti-T.
  • HY-B0273A
    Sulfadiazine sodium
    Inhibitor ≥98.0%
    Sulfadiazine sodium is a sulfonamide antibiotic with antimalarial activity.
  • HY-N8707
    Homobutein
    Inhibitor
    Homobutein a natural chalcones (can be found in many medicinal plants, fruits, vegetables, spices and nuts), is a potent HDACs/NF-κB dual inhibitor with IC50s of 190 and 38 μM, respectively.